Membrane-permeant activator of protein kinase A which does not activate Epac. Increased metabolic stability. Selects the A site of cAK I and thus can be used for synergistic activation when combined with the site B I-selective analogues 2-Cl-8-HA-cAMP (Cat. No. C 071) or 2-Cl-8-MA-cAMP (Cat. No. C 080) or 8-HA-cAMP (Cat. No. H 006).
BLG-B055-25 (5 x 5 µmol pack size) is not sold in the U.S. or Canada. Please contact us for available options.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
| Regulatory Status |
RUO – Research Use Only |
|---|
Lab Essentials
AMPIVIEW® RNA probes
Enabling Your Projects
GMP Services
Bulk Solutions
Research Travel Grant
Have You Published Using an Enzo Product?